Phenotypic resistance to thrombin-induced platelet microbicidal protein in vitro is correlated with enhanced virulence in experimental endocarditis due to Staphylococcus aureus

Infection and Immunity

Volumn 65, Issue 8, 1997, Pages 3293-3299

  Dhawan, V K ^a,b   Yeaman, M R ^b,c   Cheung, A L ^d   Kim, E ^e   Sullam, P M ^e   Bayer, A S ^b,c  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c St John's Cardiovascular Research Center   (United States)

^d ROCKEFELLER UNIVERSITY   (United States)

^e SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CELL PROTEIN; THROMBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIAL VIRULENCE; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; RABBIT; STAPHYLOCOCCUS AUREUS; TRANSPOSON;

EID: 0030760775     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.8.3293-3299.1997     Document Type: Article

References (37)

1. Balwit, J. M., P. van Lageveelde, J. M. Vann, and R. A. Proctor. 1994. Gentamicin-resistant menodione and hemin auxotrophic Staphylococcus au- reus persist within cultured endothelial cells. J. Infect. Dis. 170:1033-1037.
2. Bayer, A. S., D. C. Norman, C. V. Chiu, and C. Nast. 1989. Pathogcnetic effects of neutropenia, monocytopenia and steroid treatment in experimental Pseudomonas endocarditis. Chemotherapy 35:278-288.
3. Bayer, A. S., P. M. Sullam, M. Ramos, C. Li, A. L. Cheung, and M. R. Yeaman. 1995. Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domains. Infect. Immun. 63:3634-3641.
4. 3a.Bayer, A. S., M. R. Yeaman, S.-P. Koo, and R. Prasad. 1997. Resistance to staphylocidal effects of thrombin-induced platelet microbicidal protein (tPMP) is associated with alterations in membrane fluidity and lipid content. abstr. A-107, p. 19. In Abstracts of the 97th General Meeting of the American Society of Microbiology 1997. American Society of Microbiology. Washington, D.C.
5. Cheung, A. L., K. J. Eherhardt, E. Chung, M. R. Yeaman, P. M. Sullam, M. C. Ramos, and A. S. Bayer. 1994. Diminished virulence of a sar/agr mutant of Staphylococcus aureus in the rabbit model of endocarditis. J. Clin. Invest. 94:1815-1822.
6. Cheung, A. L., C. Wolz, M. R. Yeaman, and A. S. Bayer. 1995. Insertional inactivation of a chromosomal locus that modulates expression of potential virulence determinants in Staphylococcus aureus. J. Bacteriol. 177:3220-3226.
7. Cheung, A. L., M. R. Yeaman, P. M. Sullam, M. D. Witt, and A. S. Bayer. 1994. Role of sar locus of Staphylococcus aureus in induction of endocarditis in rabbits. Infect. Immun. 62:1719-1725.
8. Dankert, J., J. van der Werff, S. A. Zaat, W. Joldersma, D. Klein, and J. Hess. 1995. Involvement of bacterial factors from thrombin-stimulated platelets in clearance of adherent viridans streptococci in experimental infective endocarditis. Infect. Immun. 63:663-671.
9. Drake, T. A., and M. Pang. 1988. Staphylococcus aureus induces tissue factor expression in cultured human cardiac valve endothelium. J. Infect. Dis. 157:749-756.
10. Drake, T. A., and M. Pang. 1989. Effects of interleukin-1, lipopolysaccharide and streptococci on procoagulant activity of cultured human cardiac valve endothelial and stromal cells. Infect. Immun. 57:507-512.
11. Du rack, D. T. 1975. Experimental bacterial endocarditis. IV. Structure and evolution of the very early lesions. J. Clin. Pathol. 45:81-89.
12. Durack, D. T., and P. B. Beeson. 1972. Experimental bacterial endocarditis. I. Colonization of a sterile vegetation. Br. J. Exp. Pathol. 53:44-49.
13. Flock, J.-I., S. A. Heinz, A. Heimdahl, and T. Schennings. 1996. Reconsideration of the role of fibronectin binding in endocarditis caused by Staphylococcus aureus. Infect. Immun. 64:1876-1878.
14. Groisman, E. A., C. Parra-Lopez, M. Salcedo, C. J. Lipps, and F. Heffron. 1992. Resistance to host antimicrobial peptides is necessary for Salmonella virulence. Proc. Natl. Acad. Sci. USA 89:11939-11943.
15. Hackbarth, C. J., and H. F. Chambers. 1989. Methicillin-resistant staphylococci: genetics and mechanisms of resistance. Antimicrob. Agents Chemother. 33:991-994.
16. Hermann, M., S. J. Suchard, L. A. Boxer, F. A. Waldvogel, and D. P. Lew. 1992. Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adherence to surfaces. Infect. Immun. 59:279-288.
17. Herzberg, M. C., K. Gong, G. D. MacFarlane, P. R. Erickson, A. H. Soberay, P. H. Kresbach, G. Manjula, K. Schilling, and W. H. Bowen. 1990. Phenotypic characterization of Streptococcus sanguis virulence factors associated with bacterial endocarditis. Infect. Immun. 58:512-522.
18. Herzberg, M. C., G. D. MacFarlane, K. E. Gong, N. N. Amstrong, A. R. Witt, P. R. Erickson, and M. W. Meyer. 1992. The platelet interactivity phenotype of Streptococcus sanguis influences the course of experimental endocarditis. Infect. Immun. 60:4809-4818.
19. Livornese, L. L., Jr., and O. M. Korzeniowski. 1992. Pathogenesis of infective endocarditis, p. 19-35. In 2nd ed. D. Kaye (ed.). Infective endocarditis, Raven Press, New York, N.Y.
20. Moreillon, P., J. Entenza, P. Francioli, D. McDevitt, T. Foster, P. Francois, and P. Vaudaux. 1995. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect. Immun. 63:4738-1743.
21. Novick, R. 1991. Genetic systems in staphylococci. Methods Enzymol. 204:587-636.
22. Perlman, B. B., and L. S. Freedman. 1971. Experimental endocarditis. II. Staphylococcal infection of the aortic valve following placement of a polyethylene catheter in the left side of the heart. Yale J. Biol. Med. 42:394-410.
23. Prober, C. G., S. S. Dougherty, K. L. Vosti, and A. S. Yaeger. 1979. Comparison of a micromethod for performance of the serum bactericidal test with the standard tube dilution method. Antimicrob. Agents Chemother. 21:46-48.
24. Ramos, M. C., M. Ing, E. Kim, M. D. Witt, and A. S. Bayer. 1990. Ampicillinsulbactam is effective in prevention and therapy of experimental endocarditis caused by β-lactamase-producing coagulase-negative staphylococci. Antimicrob. Agents Chemother. 40:97-101.
25. Scheld, W. M., J. A. Valone, and M. A. Sande. 1978. Bacterial adherence in the pathogenesis of endocarditis: interaction of bacterial dextran, platelets and fibrin. J. Clin. Invest. 68:1344-1404.
26. Struelens, M. J., A. Deplano, C. Godard, N. Mats, and E. Serruys. 1942. Epidemiologic typing and delineation of genetic relatedness of Staphylococcus aureus by macrorestriction analysis of genomic DNA by using pulsedfield gel electrophoresis. J. Clin. Microbiol. 30:2599-2605.
27. Sullam, P. M., A. S. Bayer, W. M. Foss, and A. L. Cheung. 1996. Diminished platelet binding in vitro by Stuphylococcits tiutvus is associated with reduced virulence in a rabbit endocarditis model. Infect. Immun. 64:4915-4921.
28. Sullam, P. M., U. Frank, M. G. Tauber, M. R. Yeaman, A. S. Bayer, and H. F. Chambers. 1993. Effect of thrombocytopenia tin the early course of streptococcal endocarditis. J. Infect. Dis. 168:910-914.
29. Tunkel, A. R., and W. M. Scheld. 1992. Experimental models of endocarditis, p. 37-56. In D. Kaye (ed.), Infective endocarditis, 2nd ed. Raven Press, New York.
30. Wu, T., M. R. Yeaman, and A. S. Bayer. 1994. In vitro resistance to platelet microbicidal protein correlates with endocarditis source among staphylococcal isolates. Antimicrob. Agents Chemother. 38:729-732.
31. Yeaman, M. R., A. Ibrahim, S. G. Filler, A. S. Bayer, J. E. Edwards, Jr., and M. A. Ghannoum. 1993. Thrombin-induced rabbit platelet microbicidal protein is fungicidal in vitro. Antimicrob. Agents Chemother. 37:546-553.
32. Yeaman, M. R., D. C. Norman, and A. S. Bayer. 1992. Platelet microbicidal protein enhances antibiotic-induced killing of and postantibiotic effects in Staphyloccus aureus. Antimicrob. Agents Chemother. 36:1665-1670.
33. Yeaman, M. R., S. M. Puentes, D. C. Norman, and A. S. Bayer, 1992. Partial purification and staphylocidal activity of thrombin-induced platelet microbicidal protein. Infect. Immun. 60:1202-1209.
34. Yeaman, M. R., S. S. Soldan, M. A. Ghannoum, J. F. Edwards, Jr., S. G. Filler, and A. S. Bayer. 1996. Resistance to platelet microbicidal protein resls in increased severity of experimental Candida albicans endocarditis. Infect. Immun. 64:1379-1384.
35. Yeaman, M. R., P. M. Sullam, P. F. Dazin, and A. S. Bayer. 1994. Platelet microbicidal protein alone and in combination with antibiotics reduces Staphylococcus aureus adherence to platelets in vitro. Infect. Immun. 62:3416-3423.
36. Yeaman, M. R., Y.-Q. Tang, A. J. Shen, A. S. Bayer, and M. E. Selsted. 1996. Purification and antimicrobial activities of rabbit platelet microbicidal proteins. Infect. Immun. 65:1023-1031.
37. Yeaman, M. R., P. M. Sullam, S. P. Koo, W. Foss, and A. S. Bayer. 1997. Platelet microbicidal proteins (PMPs) differentially depolarize and permeabilize the Staphylococcus aureus cytoplasmic membranes to effect microbicidal activity in vitro, abstr. A-104, p. 18. In Abstracts of the 97th General Meeting of the American Society for Microbiology 1997. American Society for Microbiology. Washington, D.C.